Hypertension among adults aged 30-79 years, prevalence, crude in Serbia
Serbia: Hypertension among adults aged 30-79 years, prevalence, crude was 52.6 in 2019. ▲ Rising
Hypertension among adults aged 30-79 years, prevalence, crude in Serbia, 1990–2019
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for hypertension among adults aged 30-79 years, prevalence, crude in Serbia is 52.6, measured in 2019. That is the highest value across all 30 years on record.
Compared with earlier readings it is up 1.5% over ten years.
Over the whole period, hypertension among adults aged 30-79 years, prevalence, crude in Serbia peaked at 52.6 in 2015 and was at its lowest, 50.4, in 1993.
Serbia ranks 8th of 193 countries on this measure, in the top 10%.
The long-run direction has been consistently rising across the 30 years of available data.
Hypertension among adults aged 30-79 years, prevalence, crude in Serbia, year by year
| Year | Value | Change |
|---|---|---|
| 1990 | 50.7 | — |
| 1991 | 50.6 | -0.2% |
| 1992 | 50.5 | -0.2% |
| 1993 | 50.4 | -0.2% |
| 1994 | 50.4 | +0.0% |
| 1995 | 50.4 | +0.0% |
| 1996 | 50.4 | +0.0% |
| 1997 | 50.4 | +0.0% |
| 1998 | 50.5 | +0.2% |
| 1999 | 50.6 | +0.2% |
| 2000 | 50.8 | +0.4% |
| 2001 | 50.8 | +0.0% |
| 2002 | 50.9 | +0.2% |
| 2003 | 51 | +0.2% |
| 2004 | 51.1 | +0.2% |
| 2005 | 51.3 | +0.4% |
| 2006 | 51.4 | +0.2% |
| 2007 | 51.5 | +0.2% |
| 2008 | 51.6 | +0.2% |
| 2009 | 51.8 | +0.4% |
| 2010 | 51.9 | +0.2% |
| 2011 | 52 | +0.2% |
| 2012 | 52.1 | +0.2% |
| 2013 | 52.3 | +0.4% |
| 2014 | 52.4 | +0.2% |
| 2015 | 52.6 | +0.4% |
| 2016 | 52.6 | +0.0% |
| 2017 | 52.6 | +0.0% |
| 2018 | 52.6 | +0.0% |
| 2019 | 52.6 | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 50.49 | 50.4 | 50.7 | 10 |
| 2000s | 51.22 | 50.8 | 51.8 | 10 |
| 2010s | 52.37 | 51.9 | 52.6 | 10 |
Countries ranked near Serbia
More health data for Serbia
- Un projection of annual infant deaths, annual growth rate -5.26 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.3584 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,502 deaths per 1,000 people (2090)
- Number of infants who die before age 1 18 deaths (2100)
- Population ages 15-19, male, annual growth rate -0.9083 % change on previous year (2025)
- Population ages 15-19, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 15-19, male, per capita 0.0249 units per person (2025)
- Population ages 20-24, female, annual growth rate -0.457 % change on previous year (2025)
- Population ages 20-24, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 20-24, female, per capita 0.0263 units per person (2025)
Frequently asked questions
- What is hypertension among adults aged 30-79 years, prevalence, crude in Serbia?
- Hypertension among adults aged 30-79 years, prevalence, crude in Serbia was 52.6 in 2019, according to World Health Organization, Global Health Observatory.
- What is the highest hypertension among adults aged 30-79 years, prevalence, crude recorded in Serbia?
- The highest recorded value was 52.6 in 2015.
- What is the lowest hypertension among adults aged 30-79 years, prevalence, crude recorded in Serbia?
- The lowest recorded value was 50.4 in 1993.
- How does Serbia rank for hypertension among adults aged 30-79 years, prevalence, crude?
- Serbia ranks 8th out of 193 countries with data for 2019.
- Is hypertension among adults aged 30-79 years, prevalence, crude rising or falling in Serbia?
- Over the last ten years it is up 1.5%. The long-run trend across the full record is rising.
- Where does this Serbia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hypertension among adults aged 30-79 years, prevalence, crude. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 30 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).